Overview

  • Product nameDorsomorphin (Compound C)
  • Description
    Potent, selective and reversible AMP-kinase inhibitor. Selective for BMP signaling.
  • Alternative names
    • Compound C
  • Biological descriptionPotent, selective and reversible inhibitor of AMP-kinase (Ki = 109 nM). Inhibits AMPK activation induced by AICAR (ab120358) and metformin (ab120847). Selective inhibitor of bone morphogenetic protein (BMP) type I receptors (ALK2, ALK3 and ALK6). Does not affect ZAPK, SYK, PKCθ, PKA and JAK3. Cell-permeable.
    Also available in a water soluble form (Dorsomorphin dihydrochloride - ab144821)
  • Purity> 99%

Properties

    References for Dorsomorphin (Compound C) (ab120843)

    This product has been referenced in:
    • Vucicevic L  et al. Compound C induces protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway. Autophagy 7:40-50 (2011). Read more (PubMed: 20980833) »
    • Kudo TA  et al. Dorsomorphin stimulates neurite outgrowth in PC12 cells via activation of a protein kinase A-dependent MEK-ERK1/2 signaling pathway. Genes Cells 16:1121-32 (2011). Read more (PubMed: 21988724) »
    • Zhou G  et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-74 (2001). Read more (PubMed: 11602624) »

    See all 2 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120843.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"